Efficiency and biocompatibility of antimicrobial textile material of broad spectrum activity

The subject of this article is to study the behavior of the antimicrobial textile material. The material is in the form of plaster wound dressing which is consisting of a nonwoven textile base containing polypropylene (PP)/viscose, a polymer carrier, and an antimicrobial active substance. The polyme...

Full description

Saved in:
Bibliographic Details
Published in:Journal of applied polymer science Vol. 120; no. 3; pp. 1459 - 1467
Main Authors: SIMOVIC, Ljiljana M, KUNDRIC, Petar D. S, KOSTIC, Mirjana M, TASIC, Goran M, KOJIC, Zvezdana Z, MILAKOVIE, Branko D, MEDOMC, Adela H
Format: Journal Article
Language:English
Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 05-05-2011
Wiley
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The subject of this article is to study the behavior of the antimicrobial textile material. The material is in the form of plaster wound dressing which is consisting of a nonwoven textile base containing polypropylene (PP)/viscose, a polymer carrier, and an antimicrobial active substance. The polymer carrier is the polysaccharide D-glucosamine (chitosan), and the active antimicrobial substance is antibiotic gentamicin sulfate. The amount of gentamicin sulfate immobilized into the polymer matrix of the polymer carrier was 0.15-0.20 mg/cm² or 2.0-2.5% of the mass of the nonwoven textile material. The antimicrobial textile material has been studied in vitro and in vivo conditions through the efficiency of the antimicrobial effects on different kinds of pathogenic microorganisms, as well as the biocompatibility in preclinical research. The results of these experiments indicate that all bioactive textile materials were biocidal in vitro for all pathogenic test organisms. Good biocompatibility, the existence of the correlation between the in vitro and in vivo results, concerning efficiency, qualifies these antimicrobial biomaterials for clinical use.
Bibliography:http://dx.doi.org/10.1002/app.33235
istex:121C423E75D0164672AA5A143BA5105A03269211
Ministry of Science of the Republic Serbia
ark:/67375/WNG-175872CS-G
ArticleID:APP33235
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-8995
1097-4628
1097-4628
DOI:10.1002/app.33235